 Shares of nano-cap biopharma NanoViricides, Inc. NASDQ: NNVC were trading solidly higher Tuesday following a positive data readout. What Happened: Two NanoViricides COVID-19 clinical drug candidates NV-CoV-2 and NV-CoV-2-R have shown strong pan-coronavirus effectiveness in preclinical studies, the company said. 